Xilio Therapeutics, Inc. announced a private placement of 1,953,125 common shares at a price of $0.64 per share for the gross proceeds of $1,250,000 and prefunded warrants at a price of $0.6399 per prefunded warrant for the total gross proceeds of $11,300,000 on March 28, 2024. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +4.13% | +20.00% | +129.09% |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
04-01 | Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
64.58 USD | -0.52% | -1.15% | 80.53B | ||
1.26 USD | +4.13% | +20.00% | 46.5M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+129.09% | 46.5M | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilio Therapeutics, Inc. announced that it expects to receive $11.3 million in funding